Journal article
Anabolic and anticatabolic agents used in burn care: What is known and what is yet to be learned
Abstract
Major thermal injury induces profound metabolic derangements secondary to an inflammatory "stress-induced" hormonal environment. Several pharmacological interventions have been tested in an effort to halt the hypermetabolic response to severe burns. Insulin, insulin growth factor 1, insulin growth factor binding protein 3, metformin, human growth hormone, thyroid hormones, testosterone, oxandrolone, and propranolol, among others, have been …
Authors
Gus EI; Shahrokhi S; Jeschke MG
Journal
Burns, Vol. 46, No. 1, pp. 19–32
Publisher
Elsevier
Publication Date
February 2020
DOI
10.1016/j.burns.2018.03.009
ISSN
0305-4179